ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), a ground-breaking technology being developed to visualize tissue like CT or MRI, but at 1/50th of the cost, at the point of patient care. 

TAEUS is initially focused on the measurement of fat in the liver, as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. 

Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Medical Devices

ENDRA Life Sciences

Francois Michelon

Scott Sober

Michael Thornton

Steve Freeman

Irina Pestrikova

The Leadership Team at ENDRA Life Sciences is responsible for setting the strategic direction and vision of the company, driving innovation in the development of TAEUS™ technology. This team oversees operations, ensures alignment with corporate goals, and fosters partnerships to expand the clinical applications of TAEUS, ultimately aiming to enhance patient care through more accessible and cost-effective diagnostic solutions.

Leadership Team

Research and Development Team

Engineering Team

Leadership Team

About

Team members

Other teams at ENDRA Life Sciences

Research and Development Team

Engineering Team